Quarry LP’s Praxis Precision Medicines PRAX Stock Holding History

Quarry LP’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$922K	Buy	2,754 +4	+0.1%	+$1.27K	0.08%	96
2026 Q1	$886K	Sell	2,750 -1,250	-31%	-$387K	0.16%	106
2025 Q4	$1.18M	Sell	4,000 -16,001	-80%	-$2.98M	0.18%	78
2025 Q3	$1.06M	Buy	20,001 +15,201	+317%	+$737K	0.23%	71
2025 Q2	$202K	Buy	4,800 +900	+23%	+$34.3K	0.04%	352
2025 Q1	$148K	Sell	3,900 -300	-7%	-$18.7K	0.03%	378
2024 Q4	$323K	Buy	4,200 +3,200	+320%	+$232K	0.05%	195
2024 Q3	$57.5K	Sell	1,000 -1,000	-50%	-$54K	0.01%	660
2024 Q2	$82.7K	Buy	+2,000	New	+$94.5K	0.02%	428

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Quarry LP's PRAX Position: Q2 2026 in Review

Quarry LP increased its Praxis Precision Medicines (PRAX) stake by 0.15% in Q2 2026, buying an estimated $1.27K and bringing the position to 2,754 shares worth $922K. The position accounts for 0.08% of the portfolio, ranked #96.

Quarry LP first reported a position in PRAX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.18M in Q4 2025. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Quarry LP held 2,754 shares of Praxis Precision Medicines worth $922K as of Q2 2026.
Quarry LP bought 4 Praxis Precision Medicines shares in Q2 2026, an estimated $1.27K.
Praxis Precision Medicines made up 0.08% of Quarry LP's portfolio in Q2 2026, its #96 holding.
Quarry LP first reported a position in Praxis Precision Medicines in Q2 2024 and has held it in 9 quarters since.
Quarry LP's Praxis Precision Medicines position peaked at $1.18M in Q4 2025.
310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.